This inventor holds 4 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. , Deutsches Zentrum Fur Neurodegenrative Erkankung. Active years: 2014-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 1,334 
1 out of 1 Years Active: 2014-2025
Title: Innovations and Contributions of Inventor Markus Zweckstetter
Introduction
Markus Zweckstetter is a notable inventor based in Göttingen, Germany. He has made significant contributions to the field of molecular biology and biochemistry, particularly in the study of organic molecules and neurodegenerative diseases. With a total of 4 patents, Zweckstetter's work has advanced our understanding of molecular interactions and their implications in health.
Latest Patents
One of his latest patents is titled "Method for determination of the anisotropic parameters for the configuration of organic molecules embedded in alignment media." This invention outlines a method for determining molecular parameters of a known single organic molecule within an anisotropic environment. The process involves defining a three-dimensional grid aligned with the atomic structure of the alignment medium, placing the particles of the organic molecule on the grid, and calculating anisotropic parameters through nuclear magnetic resonance (NMR) spectroscopy.
Another significant patent is "Mutant alpha-synuclein, and methods using same." This invention relates to a mutant form of human alpha-synuclein that exhibits increased toxicity compared to its wild-type counterpart. The patent details specific amino acid substitutions that enhance the toxicity of the protein and provides methods for identifying substances that can mitigate this toxicity.
Career Highlights
Throughout his career, Markus Zweckstetter has worked with prestigious organizations such as the Max Planck Society for the Advancement of Science and the German Center for Neurodegenerative Diseases. His research has been pivotal in understanding the molecular mechanisms underlying neurodegenerative disorders.
Collaborations
Zweckstetter has collaborated with esteemed colleagues, including Christian Griesinger and Pinar Karpinar. These collaborations have further enriched his research and contributed to the advancement of knowledge in his field.
Conclusion
Markus Zweckstetter's innovative work and patents have significantly impacted the fields of molecular biology and neurodegenerative disease research. His contributions continue to pave the way for future discoveries and advancements in science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile